Rivive Spray
Product Images NDC 82954-0100

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rivive (NDC 82954-0100). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harm Reduction Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Step 1 (Image 01)

An instructional illustration labeled Step 1, showing a person checking another individual by shaking their shoulder and speaking loudly to wake them up. The image is part of usage instructions for a nasal spray product.*

FDA Label Image

Step 2 (Image 02)

An instructional illustration labeled 'STEP 2 GIVE' showing a hand administering a nasal spray. The hand is positioned to squirt the spray into a nose, demonstrating the proper technique for using the product.*

FDA Label Image

Step 3 (Image 03)

An instructional illustration labeled 'STEP 3 CALL 911' showing a hand holding a mobile phone displaying the number 911, with an emergency ambulance vehicle illustrated in the background.*

FDA Label Image

Step 4 (Image 04)

An instructional illustration labeled 'STEP 4 WATCH/GIVE' showing a person administering a nasal spray by spraying into another person's nose, with a clock indicating a timing of 2-3 minutes for observation or action.*

FDA Label Image

Step 5 (Image 05)

An instructional illustration labeled 'STEP 5 STAY' showing a person sitting on the ground while another person stands nearby, with an ambulance arriving in the background. This image suggests remaining with the individual after administering care or awaiting emergency services.*

FDA Label Image

Image-01 (Image 06)

RiVive naloxone hydrochloride nasal spray 3 mg/.1 mL spray packaging label by Harm Reduction Therapeutics, Inc. The label states it is for emergency treatment of opioid overdose and contains 2 single-dose nasal spray devices. The design features usage instructions, drug facts, and highlights the spray is for nasal use only with a plunger and nozzle shown on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.